Sopartec
Sopartec, part of LTTO, transfers UCLouvain research to market via spin-offs and licenses. Partners with VIVES Funds to invest in UCLouvain spin-offs and startups in Belgium and neighboring regions.
Funding Stage: Series C & Beyond
Investor type: VC Firm
Investment Areas: Med-Tech, Deep-Tech, Health-Tech, Bio-Tech
Country: Belgium
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.